Differences in glycosylation of haptoglobin between control and all LC subtypes are statistically significant, whereas for hemopexin, the glycosylation level allows differentiation of control from late-stage AC and SCC, as well as early-stage SCLC (Table S5). The gene discussed is HPX; the disease is laryngotracheoesophageal cleft.